Chester Wong is Vice President, Head of Business Development at Cartography Biosciences. He is responsible for creating key relationships to support the company’s mission and advance its pipeline of next-generation cancer immunotherapies. Prior to Cartography, he was a Director of Business Development at Amgen where he led the execution of numerous transactions. He holds a master’s degree in Bioscience from Keck Graduate Institute and a bachelor’s degree in Molecular Cell Biology from the University of California, Berkeley. In his spare time, Chester enjoys traveling to explore global cuisines and dialing in his espresso machine in search of the perfect shot.
Recent Posts
- Cartography Announces Appointment of Troy Wilson, Ph.D., J.D., to its Board of Directors
- Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs
- Cartography Biosciences Expands Leadership Team with Appointment of Dan Rock, Ph.D., as Chief Scientific Officer to Advance Novel Oncology Programs into Clinic
- Cartography Biosciences and Nested Therapeutics: Diamonds in the rough
- Cartography Biosciences Expands Scientific Advisory Board with Leading Antibody and Bi-specific Experts
Recent Comments
No comments to show.